cannabis rescheduling

The Drug Enforcement Administration (DEA) is facing legal heat following accusations of unlawful communication with Smart Approaches to Marijuana (SAM), a leading opponent of the Biden administration’s plan to reschedule marijuana from Schedule I to Schedule III under the Controlled...

The Drug Enforcement Administration (DEA) may consider additional participants for its marijuana rescheduling hearings following a Nov. 15 order by chief administrative law judge (ALJ) John J. Mulrooney II. As MJBiz Daily reported, this development follows the withdrawal of some designated...

The U.S. Treasury Department has released its quarterly report, revealing that last year, over 830 financial institutions nationwide have officially acknowledged relationships with state-licensed cannabis businesses. According to a report from the National Organization for the Reform of Marijuana...

This article was originally published on Cannabis.net and appears here with permission. Marijuana rescheduling could permit CBD from hemp in tobacco, but not weed! A recent report from the Congressional Research Service (CRS) has ignited discussions about the potential for incorporating hemp-...

A Washington-based researcher has filed a lawsuit against the Drug Enforcement Administration (DEA), alleging multiple legal violations in the agency's process of rescheduling marijuana. As Forbes reported, the complaint, filed in the U.S. District Court for Western Washington, names the Department...

As key election results unfold, Z&A hosted a panel to examine how growth opportunities in 2025 could vary under Harris vs. Trump. As key election results unfold, Pablo Zuanic of Zuanic & Associates (Z&A) hosted a panel with industry experts to examine how the outcomes and potential...

The cannabis capital markets are getting ready for what could be their most transformative period. With the 2024 election cycle underway, changes in the regulatory landscape could significantly boost investor confidence and support the industry's growth in 2025. As MJBiz Daily reported, although...

"We're finally on the cusp of something big," said George Archos, CEO of Verano Holdings Corp (OTC:VRNOF), during his keynote conversation with Tom Zuber on Tuesday at Benzinga’s Cannabis Capital Conference. Archos was referring to the potential rescheduling of cannabis from Schedule I to...

As the 2024 elections approach, the Marijuana Policy Project (MPP) released its annual voter guide to inform citizens about where their gubernatorial and Senate candidates stand on cannabis policy reform. With over 70% of Americans supporting cannabis legalization, the stakes are high for federal...

"We’re heading into an election cycle where both major party tickets are in favor of legalization, as well as smaller reforms," said David Mangone, vice president at The Liaison Group, during Tuesday’s Benzinga Cannabis Capital Conference in Chicago, Illinois, addressing a crowded room...

Marijuana companies would be "treated like normal businesses," if the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical business expenses, go away. That's according to Darren Weiss, president of Verano Holdings Corp. (...

As the 2024 elections heat up, a look at the data reveals that publicly traded companies are indirectly supporting cannabis legalization efforts by funneling millions of dollars into Democratic candidates’ campaigns.  This alignment could prove significant for the industry, particularly...

Top Democrats from influential House committees are urging the Drug Enforcement Administration (DEA) to expedite the process of rescheduling cannabis. In a letter sent to Attorney General Merrick Garland and DEA Administrator Anne Milgram, Representatives Jerrold Nadler (D-NY) and Frank Pallone (D-...

The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable emphasis on boosting the supply of certain psychedelics for research purposes. As Marijuana Moment reported, among the substances marked for increased production...

The ongoing debate over cannabis rescheduling continues to stir discussions within the industry, with many wondering what it will mean for the future of cannabis regulation. Recent actions by federal agencies have prompted hope that rescheduling may occur within the next year, but the path remains...